US2056046A
(en)
|
1933-05-19 |
1936-09-29 |
Rhone Poulenc Sa |
Manufacture of bases derived from benz-dioxane
|
US2375138A
(en)
|
1942-05-01 |
1945-05-01 |
American Cyanamid Co |
Alkamine esters of aryloxymethyl benzoic acid
|
US2629736A
(en)
|
1951-02-24 |
1953-02-24 |
Searle & Co |
Basically substituted n-alkyl derivatives of alpha, beta, beta-triarylpropionamides
|
US2730544A
(en)
|
1952-07-23 |
1956-01-10 |
Sahyun Lab |
Alkylaminoalkyl esters of hydroxycyclohexylbenzoic acid
|
US2750387A
(en)
|
1953-11-25 |
1956-06-12 |
Searle & Co |
Basically substituted derivatives of diarylaminobenzamides
|
DE1211359B
(en)
|
1955-11-29 |
1966-02-24 |
Oreal |
Oxidant-free cold dye for human hair
|
US2928833A
(en)
|
1959-03-03 |
1960-03-15 |
S E Massengill Company |
Theophylline derivatives
|
US3174901A
(en)
|
1963-01-31 |
1965-03-23 |
Jan Marcel Didier Aron Samuel |
Process for the oral treatment of diabetes
|
US3454635A
(en)
|
1965-07-27 |
1969-07-08 |
Hoechst Ag |
Benzenesulfonyl-ureas and process for their manufacture
|
DE1914999A1
(en)
|
1968-04-04 |
1969-11-06 |
Ciba Geigy |
New guanylhydrazones and processes for their preparation
|
ES385302A1
(en)
|
1970-10-22 |
1973-04-16 |
Miquel S A Lab |
Procedure for the obtaining of trisused derivatives of etilendiamine. (Machine-translation by Google Translate, not legally binding)
|
NL167151C
(en)
|
1971-04-09 |
1981-11-16 |
Acf Chemiefarma Nv |
PROCESS FOR THE PREPARATION OF MEDICINAL PRODUCTS WITH ANTI-PARASITARY ACTION ON THE BASIS OF HALOGEN CONTAINING THE 2,2'-METHYLENE DIFENOL DERIVATIVES, AND METHOD FOR PREPARING THESE MEDICINAL COMPOUNDS.
|
DE2205815A1
(en)
|
1972-02-08 |
1973-08-16 |
Hoechst Ag |
N-(oxazolin-2-yl)-piperazine - with antitussive activity
|
JPS5512435B2
(en)
|
1972-07-01 |
1980-04-02 |
|
|
US4005208A
(en)
|
1975-05-16 |
1977-01-25 |
Smithkline Corporation |
N-Heterocyclic-9-xanthenylamines
|
US4061753A
(en)
|
1976-02-06 |
1977-12-06 |
Interx Research Corporation |
Treating psoriasis with transient pro-drug forms of xanthine derivatives
|
NO154918C
(en)
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DERIVATIVES OF 3,4,5-TRIHYDROXYPIPERIDINE.
|
DE2758025A1
(en)
|
1977-12-24 |
1979-07-12 |
Bayer Ag |
Tri:hydroxy-piperidine derivs. - useful as glucosidase inhibitors for treating diabetes etc. and as animal feed additives
|
DE2929596A1
(en)
|
1979-07-21 |
1981-02-05 |
Hoechst Ag |
METHOD FOR PRODUCING OXOALKYL XANTHINES
|
DE2951135A1
(en)
|
1979-12-19 |
1981-06-25 |
Hoechst Ag, 6230 Frankfurt |
SULFONYL UREAS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS BASED ON THESE COMPOUNDS AND THEIR USE
|
JPS5639056A
(en)
|
1980-07-16 |
1981-04-14 |
Kanebo Ltd |
Preparation of n,n,n',n'-tetraacylated nucleus halogenated aromatic diamine
|
GB2084580B
(en)
|
1980-10-01 |
1984-07-04 |
Glaxo Group Ltd |
Aminoalkyl furan derivative
|
US4382091A
(en)
|
1981-04-30 |
1983-05-03 |
Syntex (U.S.A.) Inc. |
Stabilization of 1-substituted imidazole derivatives in talc
|
JPS58164502A
(en)
|
1982-03-26 |
1983-09-29 |
Chugai Pharmaceut Co Ltd |
Herbicidal composition
|
FR2558162B1
(en)
|
1984-01-17 |
1986-04-25 |
Adir |
NOVEL XANTHINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
FI79107C
(en)
|
1984-06-25 |
1989-11-10 |
Orion Yhtymae Oy |
Process for the preparation of stable form of prazosin hydrochloride.
|
AR240698A1
(en)
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Process for the preparation of 5-(4-(2-(5-ethyl-2-pyridil)-ethoxy)benzyl)-2,4-thiazolodinedione and their salts
|
US4602023A
(en)
|
1985-06-03 |
1986-07-22 |
Warner-Lambert Company |
Diphenic acid monoamides
|
US4786755A
(en)
|
1985-06-03 |
1988-11-22 |
Warner-Lambert Company |
Diphenic acid monoamides
|
US5258380A
(en)
|
1985-06-24 |
1993-11-02 |
Janssen Pharmaceutica N.V. |
(4-piperidinylmethyl and -hetero)purines
|
GB8515934D0
(en)
|
1985-06-24 |
1985-07-24 |
Janssen Pharmaceutica Nv |
(4-piperidinomethyl and-hetero)purines
|
ES2058061T3
(en)
|
1985-10-25 |
1994-11-01 |
Beecham Group Plc |
DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT.
|
US5433959A
(en)
|
1986-02-13 |
1995-07-18 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
EP0237608B1
(en)
|
1986-03-21 |
1992-01-29 |
HEUMANN PHARMA GMBH & CO |
Crystalline anhydrous sigma-form of 2-[4-(2-furoyl-(2-piperazin)-1-yl]-4-amino-6,7-dimethoxyquinazoline hydrochloride, and process for its preparation
|
DE3750402T3
(en)
|
1986-05-05 |
1997-04-10 |
Gen Hospital Corp |
INSULINOTROPES HORMON.
|
AU619444B2
(en)
|
1986-06-02 |
1992-01-30 |
Nippon Chemiphar Co. Ltd. |
2-(2-aminobenzylsulfinyl)- benzimidazole derivatives
|
US4802924A
(en)
*
|
1986-06-19 |
1989-02-07 |
Colorcon, Inc. |
Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products
|
US4968672A
(en)
|
1987-01-02 |
1990-11-06 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adenosine receptor prodrugs
|
US4743450A
(en)
|
1987-02-24 |
1988-05-10 |
Warner-Lambert Company |
Stabilized compositions
|
JPS6440433A
(en)
|
1987-08-05 |
1989-02-10 |
Green Cross Corp |
Aqueous liquid composition of thrombin
|
US4786023A
(en)
|
1987-08-19 |
1988-11-22 |
Harris Leverett D |
Drafting implement holder
|
DE68920773T2
(en)
|
1988-05-19 |
1995-05-18 |
Chugai Pharmaceutical Co Ltd |
Quinolonecarboxylic acid derivatives.
|
US5329025A
(en)
|
1988-09-21 |
1994-07-12 |
G. D. Searle & Co. |
3-azido compound
|
US5234897A
(en)
|
1989-03-15 |
1993-08-10 |
Bayer Aktiengesellschaft |
Herbicidal 3-amino-5-aminocarbonyl-1,2,4-triazoles
|
DE3926119A1
(en)
|
1989-08-08 |
1991-02-14 |
Bayer Ag |
3-AMINO-5-AMINOCARBONYL-1,2,4-TRIAZOLE DERIVATIVES
|
GB8906792D0
(en)
|
1989-03-23 |
1989-05-10 |
Beecham Wuelfing Gmbh & Co Kg |
Treatment and compounds
|
DE3916430A1
(en)
|
1989-05-20 |
1990-11-22 |
Bayer Ag |
METHOD FOR PRODUCING 3-AMINO-5-AMINOCARBONYL-1,2,4-TRIAZOLE DERIVATIVES
|
US5332744A
(en)
|
1989-05-30 |
1994-07-26 |
Merck & Co., Inc. |
Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists
|
IL94390A
(en)
|
1989-05-30 |
1996-03-31 |
Merck & Co Inc |
Di-substituted imidazo fused 6-membered nitrogen-containing heterocycles and pharmaceutical compositions containing them
|
US5223499A
(en)
|
1989-05-30 |
1993-06-29 |
Merck & Co., Inc. |
6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists
|
FI94339C
(en)
|
1989-07-21 |
1995-08-25 |
Warner Lambert Co |
Process for the preparation of pharmaceutically acceptable [R- (R *, R *)] - 2- (4-fluorophenyl) -, - dihydroxy-5- (1-methylethyl) -3-phenyl-4 - [(phenylamino) carbonyl] -1H- for the preparation of pyrrole-1-heptanoic acid and its pharmaceutically acceptable salts
|
HU208115B
(en)
|
1989-10-03 |
1993-08-30 |
Biochemie Gmbh |
New process for producting pleuromutilin derivatives
|
FR2654935B1
(en)
|
1989-11-28 |
1994-07-01 |
Lvmh Rech |
USE OF XANTHINES, WHICH MAY BE INCORPORATED IN LIPOSOMES, TO PROMOTE PIGMENTATION OF THE SKIN OR HAIR.
|
DE122007000050I1
(en)
|
1990-02-19 |
2007-11-08 |
Novartis Ag |
acyl compounds
|
KR930000861B1
(en)
|
1990-02-27 |
1993-02-08 |
한미약품공업 주식회사 |
Omeprazole rectal composition
|
DE69104453T2
(en)
|
1990-09-13 |
1995-03-16 |
Akzo Nv |
Stabilized solid chemical compositions.
|
GB9020959D0
(en)
|
1990-09-26 |
1990-11-07 |
Beecham Group Plc |
Novel compounds
|
US5084460A
(en)
|
1990-12-24 |
1992-01-28 |
A. H. Robins Company, Incorporated |
Methods of therapeutic treatment with N-(3-ouinuclidinyl)-2-hydroxybenzamides and thiobenzamides
|
US5594003A
(en)
|
1991-02-06 |
1997-01-14 |
Dr. Karl Thomae Gmbh |
Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists
|
US5602127A
(en)
|
1991-02-06 |
1997-02-11 |
Karl Thomae Gmbh |
(Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists
|
US5591762A
(en)
|
1991-02-06 |
1997-01-07 |
Dr. Karl Thomae Gmbh |
Benzimidazoles useful as angiotensin-11 antagonists
|
GB9109862D0
(en)
|
1991-05-08 |
1991-07-03 |
Beecham Lab Sa |
Pharmaceutical formulations
|
DE4124150A1
(en)
|
1991-07-20 |
1993-01-21 |
Bayer Ag |
SUBSTITUTED TRIAZOLES
|
US5300298A
(en)
|
1992-05-06 |
1994-04-05 |
The Pennsylvania Research Corporation |
Methods of treating obesity with purine related compounds
|
GB9215633D0
(en)
|
1992-07-23 |
1992-09-09 |
Smithkline Beecham Plc |
Novel treatment
|
ATE165360T1
(en)
|
1992-07-31 |
1998-05-15 |
Shionogi & Co |
TRIAZOLYLTHIOMETHYLTHIOCEPHALOSPORINE HYDROCHLORIDE, ITS CRYSTALLINE HYDRATE AND ITS PREPARATION
|
TW252044B
(en)
|
1992-08-10 |
1995-07-21 |
Boehringer Ingelheim Kg |
|
DE4242459A1
(en)
|
1992-12-16 |
1994-06-23 |
Merck Patent Gmbh |
imidazopyridines
|
CA2118117A1
(en)
|
1993-02-18 |
1994-08-19 |
Shigeki Fujiwara |
Adenosine uptake inhibitor
|
FR2707641B1
(en)
|
1993-07-16 |
1995-08-25 |
Fournier Ind & Sante |
Compounds of imidazol-5-carboxamide, their process for preparing their intermediates and their use in therapy.
|
DE4339868A1
(en)
|
1993-11-23 |
1995-05-24 |
Merck Patent Gmbh |
imidazopyridazines
|
DE4404183A1
(en)
|
1994-02-10 |
1995-08-17 |
Merck Patent Gmbh |
4-amino-1-piperidylbenzoylguanidine
|
US5545745A
(en)
|
1994-05-23 |
1996-08-13 |
Sepracor, Inc. |
Enantioselective preparation of optically pure albuterol
|
CO4410190A1
(en)
|
1994-09-19 |
1997-01-09 |
Lilly Co Eli |
3- [4- (2-AMINOETOXI) -BENZOIL] -2-ARIL-6-HYDROXYBENZO [b] CRYSTALLINE THIOPHEN
|
EP0785927B1
(en)
|
1994-10-12 |
2003-08-27 |
Euroceltique S.A. |
Novel benzoxazoles
|
GB9501178D0
(en)
|
1995-01-20 |
1995-03-08 |
Wellcome Found |
Guanine derivative
|
US5821366A
(en)
|
1995-05-19 |
1998-10-13 |
Chiroscience Limited |
Xanthines and their therapeutic use
|
GB9523752D0
(en)
|
1995-11-21 |
1996-01-24 |
Pfizer Ltd |
Pharmaceutical formulations
|
DE19543478A1
(en)
|
1995-11-22 |
1997-05-28 |
Bayer Ag |
Crystalline hydrochloride of {(R) - (-) - 2N- [4- (1,1-dioxido-3-oxo-2,3-dihydrobenzisothiazol-2-yl) -buytl] aminomethyl} -chroman
|
FR2742751B1
(en)
|
1995-12-22 |
1998-01-30 |
Rhone Poulenc Rorer Sa |
NOVEL TAXOIDS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
NZ326238A
(en)
|
1995-12-26 |
1999-11-29 |
Alteon Inc |
Compositons and methods for inhibiting nonenzymatic cross-linking and glycosylation (protein aging) using N-acylaminoalkylhydrazine carboximidamides
|
DE122010000020I1
(en)
|
1996-04-25 |
2010-07-08 |
Prosidion Ltd |
Method for lowering the blood glucose level in mammals
|
US5965555A
(en)
|
1996-06-07 |
1999-10-12 |
Hoechst Aktiengesellschaft |
Xanthine compounds having terminally animated alkynol side chains
|
AU1153097A
(en)
|
1996-06-07 |
1998-01-05 |
Eisai Co. Ltd. |
Stable polymorphs of donepezil (1-benzyl-4-{(5,6-dimethoxy-1-indanon)-2-yl}methylpiperidine ) hydrochloride and process for production
|
US5958951A
(en)
|
1996-06-14 |
1999-09-28 |
Novo Nordiskials |
Modified form of the R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
|
US5753635A
(en)
|
1996-08-16 |
1998-05-19 |
Berlex Laboratories, Inc. |
Purine derivatives and their use as anti-coagulants
|
CN1146567C
(en)
|
1996-09-23 |
2004-04-21 |
伊莱利利公司 |
Olanzapine dihydrate D
|
AU4699697A
(en)
|
1996-10-28 |
1998-05-22 |
Novo Nordisk A/S |
A process for the preparation of (-)-3,4-trans-diarylchromans
|
UA65549C2
(en)
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Use of glucagon-like peptides such as glp-1, glp-1 analog, or glp-1 derivative in methods and compositions for reducing body weight
|
ATE366584T1
(en)
|
1996-11-12 |
2007-08-15 |
Novo Nordisk As |
USE OF GLP-1 PEPTIDES
|
GB9623859D0
(en)
|
1996-11-15 |
1997-01-08 |
Chiroscience Ltd |
Novel compounds
|
NZ336548A
(en)
|
1996-12-24 |
2001-09-28 |
Biogen Inc |
Stable liquid interferon formulations comprising an amino acid as the stabilising agent
|
AU729614B2
(en)
*
|
1997-01-06 |
2001-02-08 |
Bpsi Holdings, Inc. |
Film coatings and film coating compositions based on dextrin
|
AU6024998A
(en)
|
1997-01-15 |
1998-08-07 |
Glycomed Incorporated |
Aryl c-glycoside compounds and sulfated esters thereof
|
DE19705233A1
(en)
|
1997-02-12 |
1998-08-13 |
Froelich Juergen C |
Preparation of stable, orally administered arginine solutions
|
US6011049A
(en)
|
1997-02-19 |
2000-01-04 |
Warner-Lambert Company |
Combinations for diabetes
|
AU731186B2
(en)
|
1997-03-13 |
2001-03-29 |
Hexal Ag |
Stabilization of acid sensitive benzimidazols with amino acid/cyclodextrin combinations
|
US5972332A
(en)
|
1997-04-16 |
1999-10-26 |
The Regents Of The University Of Michigan |
Wound treatment with keratinocytes on a solid support enclosed in a porous material
|
US6635280B2
(en)
|
1997-06-06 |
2003-10-21 |
Depomed, Inc. |
Extending the duration of drug release within the stomach during the fed mode
|
JP4083818B2
(en)
|
1997-06-06 |
2008-04-30 |
ディポメド,インコーポレイティド |
Gastric retentive oral drug dosage form for controlled release of highly soluble drugs
|
AR012894A1
(en)
|
1997-06-13 |
2000-11-22 |
Lilly Co Eli |
FORMULATION OF INSULIN IN STABLE SOLUTION, ITS USE TO PREPARE A MEDICINAL PRODUCT AND PROCESS FOR THE PREPARATION OF THE SAME.
|
JPH11124392A
(en)
|
1997-10-21 |
1999-05-11 |
Sankyo Co Ltd |
C-glycosylated aryltin compound
|
SK8402000A3
(en)
|
1997-12-05 |
2001-03-12 |
Astrazeneca Uk Ltd |
Novel compounds
|
ID21411A
(en)
|
1997-12-10 |
1999-06-10 |
Takeda Chemical Industries Ltd |
AGENTS TO TREAT GLUCOSE RESISTANCE THAT IS RISK OF HIGH DAMAGED
|
JPH11193270A
(en)
|
1997-12-26 |
1999-07-21 |
Koei Chem Co Ltd |
Production of optically active 1-methyl-3-piperidinemethanol
|
AU1688599A
(en)
|
1998-01-05 |
1999-07-26 |
Eisai Co. Ltd. |
Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes
|
CA2819705C
(en)
|
1998-02-02 |
2014-07-08 |
Trustees Of Tufts College |
Method of regulating glucose metabolism, and reagents related thereto
|
JP4523153B2
(en)
|
1998-03-19 |
2010-08-11 |
ブリストル−マイヤーズ スクイブ カンパニー |
Bilayer controlled release delivery system and method for readily soluble drugs
|
US6099859A
(en)
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
JP2002509919A
(en)
|
1998-03-31 |
2002-04-02 |
日産化学工業株式会社 |
Pyridazinone compound hydrochloride and method for producing the same
|
CA2268621A1
(en)
|
1998-04-13 |
1999-10-13 |
Takeda Chemical Industries, Ltd. |
2-pipirazinone-1-acetic acid derivative, production and use thereof
|
US6207207B1
(en)
|
1998-05-01 |
2001-03-27 |
Mars, Incorporated |
Coated confectionery having a crispy starch based center and method of preparation
|
DE19823831A1
(en)
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
New pharmaceutical use of isoleucyl thiazolidide and its salts
|
DE19828114A1
(en)
|
1998-06-24 |
2000-01-27 |
Probiodrug Ges Fuer Arzneim |
Produgs of unstable inhibitors of dipeptidyl peptidase IV
|
CO5150173A1
(en)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
COMPOUNDS N- (REPLACED GLYCLE) -2-DIPEPTIDYL-IV PEPTIDASE INHIBITING CYANOPIRROLIDINS (DPP-IV) WHICH ARE EFFECTIVE IN THE TREATMENT OF CONDITIONS MEDIATED BY DPP-IV INHIBITION
|
US6613806B1
(en)
|
1999-01-29 |
2003-09-02 |
Basf Corporation |
Enhancement of the efficacy of benzoylbenzenes
|
IT1312018B1
(en)
|
1999-03-19 |
2002-04-04 |
Fassi Aldo |
IMPROVED PROCEDURE FOR THE PRODUCTION OF NON HYGROSCOPICIDAL SALTS OF L (-) - CARNITINE.
|
AU4431000A
(en)
|
1999-05-12 |
2000-12-05 |
Fujisawa Pharmaceutical Co., Ltd. |
Novel use
|
US20040152659A1
(en)
|
1999-05-12 |
2004-08-05 |
Fujisawa Pharmaceutical Co. Ltd. |
Method for the treatment of parkinson's disease comprising administering an A1A2a receptor dual antagonist
|
AU5294100A
(en)
|
1999-05-27 |
2000-12-18 |
University Of Virginia Patent Foundation |
Method and compositions for treating the inflammatory response
|
US6545002B1
(en)
|
1999-06-01 |
2003-04-08 |
University Of Virginia Patent Foundation |
Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors
|
EE04748B1
(en)
|
1999-06-21 |
2006-12-15 |
Boehringer Ingelheim Pharma Kg |
Bicyclic heterocyclic compounds, drugs containing these compounds, their use and methods for their preparation
|
US6448323B1
(en)
*
|
1999-07-09 |
2002-09-10 |
Bpsi Holdings, Inc. |
Film coatings and film coating compositions based on polyvinyl alcohol
|
ES2166270B1
(en)
|
1999-07-27 |
2003-04-01 |
Almirall Prodesfarma Sa |
DERIVATIVES OF 8-PHENYL-6,9-DIHIDRO- (1,2,4,) TRIAZOLO (3,4-I) PURIN-5-ONA.
|
ES2216937T3
(en)
|
1999-08-31 |
2004-11-01 |
Kissei Pharmaceutical Co., Ltd. |
DERIVATIVES OF GLUCOPIRANOSILOXIPIRAZOL, MEDICINAL COMPOSITIONS THAT CONTAIN THEM AND INTERMEDIATES OBTAINED DURING THEIR PREPARATION.
|
US6515117B2
(en)
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
US6586438B2
(en)
|
1999-11-03 |
2003-07-01 |
Bristol-Myers Squibb Co. |
Antidiabetic formulation and method
|
GB9928330D0
(en)
|
1999-11-30 |
2000-01-26 |
Ferring Bv |
Novel antidiabetic agents
|
AU777776B2
(en)
|
1999-12-23 |
2004-10-28 |
Novartis Ag |
Use of hypoglycemic agent for treating impaired glucose metabolism
|
CA2396079A1
(en)
|
2000-01-07 |
2001-07-19 |
Transform Pharmaceuticals, Inc. |
High-throughput formation, identification, and analysis of diverse solid-forms
|
US6362172B2
(en)
|
2000-01-20 |
2002-03-26 |
Bristol-Myers Squibb Company |
Water soluble prodrugs of azole compounds
|
PT1741445E
(en)
|
2000-01-21 |
2013-11-11 |
Novartis Ag |
Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents
|
JP4621326B2
(en)
|
2000-02-01 |
2011-01-26 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
Teprenone stabilized composition
|
US6627611B2
(en)
|
2000-02-02 |
2003-09-30 |
Kotobuki Pharmaceutical Co Ltd |
C-glycosides and preparation of thereof as antidiabetic agents
|
JP4456768B2
(en)
|
2000-02-02 |
2010-04-28 |
壽製薬株式会社 |
Drug containing C-glycoside
|
WO2001056993A2
(en)
|
2000-02-05 |
2001-08-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compositions useful as inhibitors of erk
|
EP1295609A4
(en)
|
2000-02-24 |
2004-11-03 |
Takeda Chemical Industries Ltd |
Drugs containing combined active ingredients
|
EP1132389A1
(en)
|
2000-03-06 |
2001-09-12 |
Vernalis Research Limited |
New aza-indolyl derivatives for the treatment of obesity
|
US6395767B2
(en)
|
2000-03-10 |
2002-05-28 |
Bristol-Myers Squibb Company |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
|
GB0006133D0
(en)
|
2000-03-14 |
2000-05-03 |
Smithkline Beecham Plc |
Novel pharmaceutical
|
AR028253A1
(en)
*
|
2000-03-16 |
2003-04-30 |
Pfizer Prod Inc |
INHIBITORS OF THE GLUCOGENO FOSFORILASA
|
JP2001278812A
(en)
|
2000-03-27 |
2001-10-10 |
Kyoto Pharmaceutical Industries Ltd |
Disintegrant for tablet and tablet using the same
|
US6683056B2
(en)
|
2000-03-30 |
2004-01-27 |
Bristol-Myers Squibb Company |
O-aryl glucoside SGLT2 inhibitors and method
|
CZ20023234A3
(en)
|
2000-03-31 |
2003-01-15 |
Probiodrug Ag |
Medicament against diabetes mellitus
|
JP2001292388A
(en)
|
2000-04-05 |
2001-10-19 |
Sharp Corp |
Reproducing device
|
GB0008694D0
(en)
|
2000-04-07 |
2000-05-31 |
Novartis Ag |
Organic compounds
|
US6962998B2
(en)
|
2000-06-14 |
2005-11-08 |
Toray Industries, Inc. |
Processes for producing racemic piperidine derivative and for producing optically active piperidine derivative
|
US7078397B2
(en)
|
2000-06-19 |
2006-07-18 |
Smithkline Beecham Corporation |
Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
|
GB0014969D0
(en)
|
2000-06-19 |
2000-08-09 |
Smithkline Beecham Plc |
Novel method of treatment
|
US6488962B1
(en)
|
2000-06-20 |
2002-12-03 |
Depomed, Inc. |
Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
|
MXPA02012272A
(en)
|
2000-07-04 |
2003-04-25 |
Novo Nordisk As |
Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv.
|
ATE411285T1
(en)
|
2000-08-10 |
2008-10-15 |
Mitsubishi Tanabe Pharma Corp |
PROLINE DERIVATIVES AND THEIR USE AS MEDICATIONS
|
US6821978B2
(en)
|
2000-09-19 |
2004-11-23 |
Schering Corporation |
Xanthine phosphodiesterase V inhibitors
|
EP1329456B1
(en)
|
2000-09-29 |
2006-08-09 |
Kissei Pharmaceutical Co., Ltd. |
Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
|
US20060034922A1
(en)
|
2000-11-03 |
2006-02-16 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
US6866866B1
(en)
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
US6790459B1
(en)
|
2000-11-03 |
2004-09-14 |
Andrx Labs, Llc |
Methods for treating diabetes via administration of controlled release metformin
|
US7053060B2
(en)
|
2000-11-30 |
2006-05-30 |
Kissei Pharmaceutical Co., Ltd. |
Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof
|
EP1354882A1
(en)
|
2000-12-27 |
2003-10-22 |
Kyowa Hakko Kogyo Co., Ltd. |
Dipeptidyl peptidase iv inhibitor
|
WO2002053573A1
(en)
|
2000-12-28 |
2002-07-11 |
Kissei Pharmaceutical Co., Ltd. |
Glucopyranosyloxypyrazole derivatives and use thereof in medicines
|
FR2819254B1
(en)
|
2001-01-08 |
2003-04-18 |
Fournier Lab Sa |
NOVEL N- (PHENYLSULFONYL) GLYCINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR OBTAINING PHARMACEUTICAL COMPOSITIONS
|
DE10109021A1
(en)
|
2001-02-24 |
2002-09-05 |
Boehringer Ingelheim Pharma |
New 8-substituted-xanthine derivatives, useful e.g. for treating diabetes and arthritis, act by inhibiting dipeptidylpeptidase-IV
|
DE10117803A1
(en)
|
2001-04-10 |
2002-10-24 |
Boehringer Ingelheim Pharma |
New 8-substituted-xanthine derivatives, useful e.g. for treating diabetes and arthritis, act by inhibiting dipeptidylpeptidase-IV
|
WO2002062764A1
(en)
|
2001-02-02 |
2002-08-15 |
Takeda Chemical Industries, Ltd. |
Fused heterocyclic compounds
|
TWI255817B
(en)
|
2001-02-14 |
2006-06-01 |
Kissei Pharmaceutical |
Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
|
US6649187B2
(en)
|
2001-02-16 |
2003-11-18 |
Bristol-Myers Squibb Pharma Company |
Use of polyalkylamine polymers in controlled release devices
|
ES2444772T3
(en)
|
2001-02-24 |
2014-02-26 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, their preparation and use as medicines
|
US6936590B2
(en)
|
2001-03-13 |
2005-08-30 |
Bristol Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
US6693094B2
(en)
|
2001-03-22 |
2004-02-17 |
Chrono Rx Llc |
Biguanide and sulfonylurea formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus
|
JP3698067B2
(en)
|
2001-03-30 |
2005-09-21 |
Jsr株式会社 |
Monomer having electron-withdrawing group and electron-donating group, copolymer using the same, and proton conducting membrane
|
US6774112B2
(en)
|
2001-04-11 |
2004-08-10 |
Bristol-Myers Squibb Company |
Amino acid complexes of C-aryl glucosides for treatment of diabetes and method
|
JP2002348279A
(en)
|
2001-05-25 |
2002-12-04 |
Nippon Kayaku Co Ltd |
Production method for optically active pyridylketone derivatives and optically active pyridylketone derivatives
|
DE10130371A1
(en)
|
2001-06-23 |
2003-01-02 |
Boehringer Ingelheim Pharma |
New drug compositions based on anticholinergics, corticosteroids and betamimetics
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
BR0210644A
(en)
|
2001-06-27 |
2004-07-20 |
Smithkline Beecham Corp |
Compound, pharmaceutical formulation, method for inhibiting a proline / alanine cleaving protease, method for treatment or prophylaxis of disorders, and use of the compound
|
JP4357293B2
(en)
|
2001-06-27 |
2009-11-04 |
スミスクライン ビーチャム コーポレーション |
Fluoropyrrolidines as dipeptidyl peptidase inhibitors
|
US6869947B2
(en)
|
2001-07-03 |
2005-03-22 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
JP2005502624A
(en)
|
2001-07-03 |
2005-01-27 |
ノボ ノルディスク アクティーゼルスカブ |
Purine derivatives inhibiting DPP-IV for the treatment of diabetes
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
US7638522B2
(en)
|
2001-08-13 |
2009-12-29 |
Janssen Pharmaceutica N.V. |
Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
|
US20030087843A1
(en)
|
2001-09-05 |
2003-05-08 |
Washburn William N. |
O-pyrazole glucoside SGLT2 inhibitors and method of use
|
JP2005509603A
(en)
|
2001-09-19 |
2005-04-14 |
ノボ ノルディスク アクティーゼルスカブ |
Heterocyclic compounds that are inhibitors of the DPP-IV enzyme
|
WO2003031458A1
(en)
|
2001-10-12 |
2003-04-17 |
Dana-Farber Cancer Institute |
Methods for synthesis of diarylmethanes
|
DK1435877T3
(en)
|
2001-10-15 |
2009-08-03 |
Hemoteq Ag |
Coating of stents to prevent restenosis
|
EP2090571B1
(en)
|
2001-10-17 |
2012-05-16 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Pyrimidine derivates, medicaments comprising them, their use and process of their preparation
|
DE10151296A1
(en)
|
2001-10-17 |
2003-04-30 |
Boehringer Ingelheim Pharma |
Keratinocytes useful as a biologically active substance in the treatment of wounds
|
US6723340B2
(en)
|
2001-10-25 |
2004-04-20 |
Depomed, Inc. |
Optimal polymer mixtures for gastric retentive tablets
|
US20030083354A1
(en)
|
2001-10-26 |
2003-05-01 |
Pediamed Pharmaceuticals, Inc. |
Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions
|
US6861440B2
(en)
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
CA2363053C
(en)
|
2001-11-09 |
2011-01-25 |
Bernard Charles Sherman |
Clopidogrel bisulfate tablet formulation
|
KR20040064687A
(en)
|
2001-12-21 |
2004-07-19 |
도오레 화인케미칼 가부시키가이샤 |
Process for production of optically active cis-piperidine derivatives
|
US6727261B2
(en)
|
2001-12-27 |
2004-04-27 |
Hoffman-La Roche Inc. |
Pyrido[2,1-A]Isoquinoline derivatives
|
DE60323823D1
(en)
|
2002-01-11 |
2008-11-13 |
Novo Nordisk As |
METHOD AND COMPOSITION FOR THE TREATMENT OF DIABETES, HYPERTENSION, CHRONIC HEART FAILURE AND LIQUID RETENTION CONDITIONS
|
CZ303145B6
(en)
|
2002-01-16 |
2012-05-02 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Process for preparing bilayer pharmaceutical tablet containing telmisartan and hydrochlorothiazide
|
EP1333033A1
(en)
|
2002-01-30 |
2003-08-06 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
FAP-activated anti-tumor compounds
|
EP1469829B1
(en)
|
2002-02-01 |
2016-01-27 |
Bend Research, Inc |
Immediate release dosage forms containing solid drug dispersions
|
US7610153B2
(en)
|
2002-02-13 |
2009-10-27 |
Virginia Commonwealth University |
Multi-drug titration and evaluation
|
AU2003211146B2
(en)
*
|
2002-02-21 |
2007-07-19 |
Valeant International (Barbados) Srl |
Controlled release dosage forms
|
EP1338595B1
(en)
|
2002-02-25 |
2006-05-03 |
Eisai Co., Ltd. |
Xanthine derivatives as DPP-IV inhibitors
|
HUP0200849A2
(en)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetyl-pyrrolidine-2-carbonitrile derivatives, pharmaceutical compositions containing them and process for producing them
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
JP4298212B2
(en)
|
2002-03-29 |
2009-07-15 |
大日本印刷株式会社 |
Method for producing high melting point type epinastine hydrochloride
|
JP2003300977A
(en)
|
2002-04-10 |
2003-10-21 |
Sumitomo Pharmaceut Co Ltd |
Xanthine derivative
|
CA2480325A1
(en)
|
2002-04-16 |
2003-10-30 |
Merck & Co., Inc. |
Solid forms of salts with tyrosine kinase activity
|
CA2484306A1
(en)
|
2002-04-26 |
2003-11-06 |
Katsumi Maezono |
Prophylactic and therapeutic agent of diabetes mellitus
|
AU2003231252A1
(en)
|
2002-05-09 |
2003-11-11 |
Enos Pharmaceuticals, Inc. |
Methods and compositions for the treatment and prevention of intermittent claudication or alzheimer's disease
|
GB0212412D0
(en)
|
2002-05-29 |
2002-07-10 |
Novartis Ag |
Combination of organic compounds
|
CN101538224A
(en)
|
2002-05-31 |
2009-09-23 |
先灵公司 |
Process for preparing xanthine phosphodiesterase V inhibitors and precursers thereof
|
KR100985160B1
(en)
|
2002-06-06 |
2010-10-05 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
Novel condensed imidazole derivatives
|
FR2840897B1
(en)
|
2002-06-14 |
2004-09-10 |
Fournier Lab Sa |
NOVEL ARYLSULFONAMIDE DERIVATIVES AND THEIR USE IN THERAPEUTICS
|
US20040002615A1
(en)
|
2002-06-28 |
2004-01-01 |
Allen David Robert |
Preparation of chiral amino-nitriles
|
DE10231370B4
(en)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophene glycoside derivatives, medicaments containing these compounds and methods of making these medicaments
|
US20040023981A1
(en)
|
2002-07-24 |
2004-02-05 |
Yu Ren |
Salt forms with tyrosine kinase activity
|
TW200409746A
(en)
|
2002-07-26 |
2004-06-16 |
Theravance Inc |
Crystalline β2 adrenergic receptor agonist
|
TWI254635B
(en)
|
2002-08-05 |
2006-05-11 |
Yamanouchi Pharma Co Ltd |
Azulene derivative and salt thereof
|
MXPA05001549A
(en)
|
2002-08-08 |
2005-05-05 |
Kissei Pharmaceutical |
Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof.
|
TW200404796A
(en)
|
2002-08-19 |
2004-04-01 |
Ono Pharmaceutical Co |
Nitrogen-containing compound
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
DE10238243A1
(en)
|
2002-08-21 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
New 8-(3-amino-piperidin-1-yl)-xanthine derivatives are dipeptidylpeptidase-IV inhibitors useful for, e.g. treating diabetes mellitus, arthritis or obesity
|
EP2308878A3
(en)
|
2002-08-21 |
2011-10-26 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and use as medicaments
|
DE10238470A1
(en)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
New xanthine derivatives, their production and their use as medicines
|
US7569574B2
(en)
|
2002-08-22 |
2009-08-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Purine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
DE10238477A1
(en)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
New purine derivatives, their production and their use as medicines
|
US7495005B2
(en)
|
2002-08-22 |
2009-02-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, their preparation and their use in pharmaceutical compositions
|
DE10238724A1
(en)
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
New 6-alkyl-1,5-dihydro-4H-pyrazolo-(3,4-d)-pyrimidin-4-ones useful as selective phosphodiesterase 9A inhibitors for improving attention, concentration, learning and/or memory performance
|
DE10238723A1
(en)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Phenyl substituted pyrazolyprimidines
|
EP1537880A4
(en)
|
2002-09-11 |
2009-07-01 |
Takeda Pharmaceutical |
Sustained release preparation
|
BR0314356A
(en)
|
2002-09-16 |
2005-07-19 |
Wyeth Corp |
Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods using the same
|
NZ538936A
(en)
|
2002-09-26 |
2006-12-22 |
Eisai Co Ltd |
Combination drug comprising a combination of a dipeptidyl peptidase IV (DPPIV) inhibitor with biguanide
|
AU2003269850A1
(en)
|
2002-10-08 |
2004-05-04 |
Novo Nordisk A/S |
Hemisuccinate salts of heterocyclic dpp-iv inhibitors
|
US20040122048A1
(en)
|
2002-10-11 |
2004-06-24 |
Wyeth Holdings Corporation |
Stabilized pharmaceutical composition containing basic excipients
|
US6861526B2
(en)
|
2002-10-16 |
2005-03-01 |
Pfizer Inc. |
Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
|
DE60320008T2
(en)
|
2002-10-18 |
2009-06-18 |
Merck & Co., Inc. |
HETEROCYCLIC BETA-AMINO COMPOUNDS AS INHIBITORS OF DIPEPTIDYLPEPTIDASE FOR TREATMENT OR PREVENTION OF DIABETES
|
JP2004161749A
(en)
|
2002-10-24 |
2004-06-10 |
Toray Fine Chemicals Co Ltd |
Method for producing optically active, nitrogen-containing compound
|
AU2003280680A1
(en)
|
2002-11-01 |
2004-06-18 |
Sumitomo Pharmaceuticals Co., Ltd. |
Xanthine compound
|
JP4413863B2
(en)
|
2002-11-07 |
2010-02-10 |
メルク エンド カムパニー インコーポレーテッド |
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
DE10251927A1
(en)
|
2002-11-08 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
New 1,7,8-trisubstituted xanthine derivatives, are dipeptidylpeptidase-IV inhibitors useful e.g. for treating diabetes mellitus type I or II, arthritis or obesity
|
US7482337B2
(en)
|
2002-11-08 |
2009-01-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
JP3567162B1
(en)
|
2002-11-20 |
2004-09-22 |
日本たばこ産業株式会社 |
4-oxoquinoline compounds and their use as HIV integrase inhibitors
|
EP2272516A3
(en)
|
2002-11-20 |
2011-03-16 |
Japan Tobacco, Inc. |
4-Oxoquinoline compound and use thereof as HIV integrase inhibitor
|
DE10254304A1
(en)
|
2002-11-21 |
2004-06-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
New xanthine derivatives, their production and their use as medicines
|
UY28103A1
(en)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
NEW IMIDAZO-PIRIDINONAS REPLACED, ITS PREPARATION AND ITS EMPLOYMENT AS MEDICATIONS
|
US7109192B2
(en)
|
2002-12-03 |
2006-09-19 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions
|
JP4651934B2
(en)
|
2002-12-04 |
2011-03-16 |
キッセイ薬品工業株式会社 |
Benzylphenol derivative, pharmaceutical composition containing it, and pharmaceutical use thereof
|
CA2505771A1
(en)
|
2002-12-10 |
2004-06-24 |
Novartis Ag |
Combination of an dpp-iv inhibitor and a ppar-alpha compound
|
DE10258007B4
(en)
|
2002-12-12 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Aromatic fluoroglycoside derivatives, medicaments containing these compounds and methods for the preparation of these medicaments
|
DE10258008B4
(en)
|
2002-12-12 |
2006-02-02 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclic fluoroglycoside derivatives, medicaments containing these compounds and methods of making these medicaments
|
US20040152720A1
(en)
|
2002-12-20 |
2004-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
|
DE10351663A1
(en)
|
2002-12-20 |
2004-07-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Stable, accurately dosable inhalable powder medicament for treating asthma or chronic obstructive pulmonary disease, containing tiotropium, specific form of salmeterol xinafoate and auxiliary
|
KR20050090437A
(en)
|
2003-01-03 |
2005-09-13 |
브리스톨-마이어스 스큅 컴퍼니 |
Methods of producing c-aryl glucoside sglt2 inhibitors
|
SI1599222T1
(en)
|
2003-01-08 |
2009-08-31 |
Novartis Vaccines & Diagnostic |
Stabilized aqueous compositions comprising tissue factor pathway inhibitor (tfpi) or tissue factor pathway inhibitor variant
|
NZ540612A
(en)
|
2003-01-14 |
2008-02-29 |
Arena Pharm Inc |
1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
DE10335027A1
(en)
|
2003-07-31 |
2005-02-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Use of telmisartan and simvastatin for treatment or prophylaxis of cardiovascular, cardiopulmonary and renal diseases e.g. hypertension combined with hyperlipidemia or atherosclerosis
|
PE20040950A1
(en)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
BIPHENYL DERIVATIVES AS AGONISTS OF ß2-ADRENERGIC RECEPTORS AND AS ANTAGONISTS OF MUSCARINAL RECEPTORS
|
JP2004250336A
(en)
|
2003-02-18 |
2004-09-09 |
Kao Corp |
Method for producing coated tablet and sugar-coated tablet
|
EP1597266A4
(en)
|
2003-02-27 |
2008-02-20 |
Bristol Myers Squibb Co |
A non-cryogenic process for forming glycosides
|
US7135575B2
(en)
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
US7442387B2
(en)
|
2003-03-06 |
2008-10-28 |
Astellas Pharma Inc. |
Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
|
MXPA05009564A
(en)
|
2003-03-12 |
2005-11-17 |
Univ Arizona |
Weak base salts.
|
RU2317288C3
(en)
|
2003-03-14 |
2021-03-10 |
Астеллас Фарма Инк. |
C-GLYCOSIDE DERIVATIVES AND THEIR SALTS
|
CA2516142A1
(en)
|
2003-03-18 |
2004-09-30 |
Novartis Ag |
Compositions comprising fatty acids and amino acids
|
WO2004096806A1
(en)
|
2003-04-30 |
2004-11-11 |
Sumitomo Pharmaceuticals Co. Ltd. |
Fused imidazole derivative
|
US20040220186A1
(en)
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
US7674486B2
(en)
|
2003-05-14 |
2010-03-09 |
Indus Biotech Pvt. Ltd. |
Synergistic composition for the treatment of diabetes mellitus
|
TW200510277A
(en)
|
2003-05-27 |
2005-03-16 |
Theravance Inc |
Crystalline form of β2-adrenergic receptor agonist
|
CN1835962A
(en)
|
2003-06-03 |
2006-09-20 |
加利福尼亚大学董事会 |
Compositions and methods for treatment of disease with acetylated disaccharides
|
AU2003902828A0
(en)
|
2003-06-05 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
JP2004359630A
(en)
|
2003-06-06 |
2004-12-24 |
Yamanouchi Pharmaceut Co Ltd |
Difluorodiphenylmethane derivative and its salt
|
US7566707B2
(en)
|
2003-06-18 |
2009-07-28 |
Boehringer Ingelheim International Gmbh |
Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
|
DE10327439A1
(en)
|
2003-06-18 |
2005-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Novel imidazopyridazinone and imidazopyridone derivatives, their production and their use as pharmaceuticals
|
EA009591B1
(en)
|
2003-06-20 |
2008-02-28 |
Ф.Хоффманн-Ля Рош Аг |
Pyrido[2,1-a]-isoquinoline derivatives as dpp-iv inhibitors
|
CN101090901B
(en)
|
2003-06-20 |
2010-12-15 |
霍夫曼-拉罗奇有限公司 |
Hexahydropyridoisoqinolines as DPP-IV inhibitors
|
JO2625B1
(en)
|
2003-06-24 |
2011-11-01 |
ميرك شارب اند دوم كوربوريشن |
Phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor
|
AR045047A1
(en)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
ARILO AND HETEROARILO DERIVATIVES TRISUSTITUIDOS AS MODULATORS OF METABOLISM AND PROFILAXIS AND TREATMENT OF DISORDERS RELATED TO THEMSELVES
|
TWI335328B
(en)
|
2003-07-14 |
2011-01-01 |
Arena Pharm Inc |
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related hereto
|
ATE457166T1
(en)
|
2003-07-24 |
2010-02-15 |
Wockhardt Ltd |
ORAL COMPOSITIONS FOR TREATING DIABETES
|
EP1679965A4
(en)
|
2003-08-01 |
2009-05-27 |
Janssen Pharmaceutica Nv |
Substituted fused heterocyclic c-glycosides
|
BRPI0413234A
(en)
|
2003-08-01 |
2006-10-03 |
Genelabs Tech Inc |
bicyclic imidazole derivatives against flaviviridae
|
US6995183B2
(en)
|
2003-08-01 |
2006-02-07 |
Bristol Myers Squibb Company |
Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
|
EP1651658B2
(en)
|
2003-08-01 |
2020-08-12 |
Mitsubishi Tanabe Pharma Corporation |
Novel compounds having inhibitory activity against sodium-dependant transporter
|
JP4131216B2
(en)
|
2003-08-20 |
2008-08-13 |
Jsr株式会社 |
Polyarylene, production method thereof, solid polymer electrolyte and proton conducting membrane
|
US7375090B2
(en)
|
2003-08-26 |
2008-05-20 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyloxy-pyrazoles, pharmaceutical compositions containing these compounds, the use thereof and processed for the preparation thereof
|
CA2539032A1
(en)
|
2003-08-26 |
2005-03-10 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyloxy-pirazoles, drugs containing said compounds the use and production method thereof
|
AU2004270150C1
(en)
|
2003-08-29 |
2011-07-14 |
Merck Hdac Research, Llc |
Combination methods of treating cancer
|
US7790734B2
(en)
|
2003-09-08 |
2010-09-07 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
ATE534404T1
(en)
|
2003-10-03 |
2011-12-15 |
Takeda Pharmaceutical |
DIPEPTIDYLPEPTIDASE IV INHIBITORS FOR THE TREATMENT OF DIABETES PATIENTS WITH SECONDARY FAILURE DUE TO SULFONYL UREAS
|
US20050085680A1
(en)
|
2003-10-21 |
2005-04-21 |
Joseph Auerbach |
Method for industrial decontamination
|
KR20060109911A
(en)
|
2003-11-17 |
2006-10-23 |
노파르티스 아게 |
Use of dipeptidyl peptidase iv inhibitors
|
DE10355304A1
(en)
|
2003-11-27 |
2005-06-23 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Novel 8- (piperazin-1-yl) and 8 - ([1,4] diazepan-1-yl) xanthines, their preparation and their use as pharmaceuticals
|
WO2005053695A1
(en)
|
2003-12-04 |
2005-06-16 |
Eisai Co., Ltd. |
Preventive or therapeutic agent for multiple sclerosis
|
DE10359098A1
(en)
|
2003-12-17 |
2005-07-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Novel 2- (piperazin-1-yl) and 2 - ([1,4] diazepan-1-yl) imidazo [4,5-d] pyridazin-4-ones, their preparation and their use as pharmaceuticals
|
US7217711B2
(en)
|
2003-12-17 |
2007-05-15 |
Boehringer Ingelheim International Gmbh |
Piperazin-1-yl and 2-([1,4]diazepan-1-yl)-imidazo[4,5-d]-pyridazin-4-ones, the preparation thereof and their use as pharmaceutical compositions
|
ATE501135T1
(en)
|
2003-12-18 |
2011-03-15 |
Tibotec Pharm Ltd |
PIPERIDINAMINO-BENZIMIDAZOLE DERIVATIVES AL RESPIRATORY SYNCYTIALVIRUS REPLICATION INHIBITORS
|
DE10361133A1
(en)
|
2003-12-22 |
2005-07-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Glucopyranosyloxy-substituted aromatics, medicaments containing these compounds, their use and processes for their preparation
|
US7371732B2
(en)
|
2003-12-22 |
2008-05-13 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyloxy-substituted aromatic compounds, medicaments containing such compounds, their use and process for their manufacture
|
DE10360835A1
(en)
|
2003-12-23 |
2005-07-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
New bicyclic imidazole derivatives are dipeptidylpeptidase-IV inhibitors useful to treat e.g. arthritis, obesity, allograft transplantation and calcitonin-induced osteoporosis
|
CA2549955A1
(en)
|
2003-12-24 |
2005-07-07 |
Prosidion Limited |
Heterocyclic derivatives as gpcr receptor agonists
|
EP1758905B1
(en)
|
2004-02-18 |
2009-04-29 |
Boehringer Ingelheim International GmbH |
8-[3-amino-piperidin-1-yl]-xanthine, the production thereof and the use in the form of a ddp-iv inhibitor
|
US7501426B2
(en)
|
2004-02-18 |
2009-03-10 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
DE102004019540A1
(en)
|
2004-04-22 |
2005-11-10 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Composition, useful for treatment of e.g. inflammatory and obstructive respiratory complaint, sinus rhythm in heart in atrioventricular block and circulatory shock, comprises 6-hydroxy-4H-benzo1,4oxazin-3-one derivatives and other actives
|
DE102004009039A1
(en)
|
2004-02-23 |
2005-09-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8- [3-Amino-piperidin-1-yl] xanthines, their preparation and use as pharmaceuticals
|
JP4950657B2
(en)
|
2004-03-04 |
2012-06-13 |
キッセイ薬品工業株式会社 |
Fused heterocyclic derivative, pharmaceutical composition containing the same, and pharmaceutical use thereof
|
US7732596B2
(en)
|
2004-03-04 |
2010-06-08 |
Kissei Pharmaceutical Co., Ltd. |
Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
|
EP1593671A1
(en)
|
2004-03-05 |
2005-11-09 |
Graffinity Pharmaceuticals AG |
DPP-IV inhibitors
|
US7393847B2
(en)
|
2004-03-13 |
2008-07-01 |
Boehringer Ingleheim International Gmbh |
Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions
|
CN102134230B
(en)
|
2004-03-15 |
2019-06-28 |
武田药品工业株式会社 |
Depeptidyl peptidase inhibitors
|
EA011158B1
(en)
|
2004-03-16 |
2009-02-27 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
|
EP1577306A1
(en)
|
2004-03-17 |
2005-09-21 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
novel benzoxazinone derivatives as slow-acting betamimetics and use thereof in treatment of respiratory tract diseases
|
US7179809B2
(en)
|
2004-04-10 |
2007-02-20 |
Boehringer Ingelheim International Gmbh |
2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions
|
JP2007531780A
(en)
|
2004-04-10 |
2007-11-08 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Novel 2-amino-imidazo [4,5-D] pyridazin-4-one and 2-amino-imidazo [4,5-C] pyridazin-4-one, their preparation and use as pharmaceuticals
|
US20050239778A1
(en)
|
2004-04-22 |
2005-10-27 |
Boehringer Ingelheim International Gmbh |
Novel medicament combinations for the treatment of respiratory diseases
|
US20050244502A1
(en)
|
2004-04-28 |
2005-11-03 |
Mathias Neil R |
Composition for enhancing absorption of a drug and method
|
US7439370B2
(en)
|
2004-05-10 |
2008-10-21 |
Boehringer Ingelheim International Gmbh |
Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides
|
AU2005247684B2
(en)
|
2004-05-12 |
2008-10-23 |
Pfizer Products Inc. |
Proline derivatives and their use as dipeptidyl peptidase IV inhibitors
|
DE102004024454A1
(en)
|
2004-05-14 |
2005-12-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Novel enantiomerically pure beta agonists, process for their preparation and their use as pharmaceuticals
|
PE20060315A1
(en)
|
2004-05-24 |
2006-05-15 |
Irm Llc |
THIAZOLE COMPOUNDS AS PPAR MODULATORS
|
TWI354569B
(en)
|
2004-05-28 |
2011-12-21 |
Bristol Myers Squibb Co |
Coated tablet formulation and method
|
ZA200610041B
(en)
|
2004-06-01 |
2008-07-30 |
Ares Trading Sa |
Method of stabilizing proteins
|
US7935723B2
(en)
|
2004-06-04 |
2011-05-03 |
Novartis Pharma Ag |
Use of organic compounds
|
EP1753459A2
(en)
|
2004-06-09 |
2007-02-21 |
Yasoo Health |
Composition and method for improving pancreatic islet cell survival
|
DE102004030502A1
(en)
|
2004-06-24 |
2006-01-12 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Novel imidazoles and triazoles, their preparation and use as medicines
|
US7393836B2
(en)
|
2004-07-06 |
2008-07-01 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
|
CA2572149A1
(en)
|
2004-07-08 |
2006-01-19 |
Astellas Pharma Inc. |
Process for production of azulene derivatives and intermediates for the synthesis of the same
|
CN101018550A
(en)
|
2004-07-14 |
2007-08-15 |
诺瓦提斯公司 |
Combination of DPP-IV inhibitors and compounds modulating 5-HT3 and/or 5-HT4 receptors
|
DE102004034690A1
(en)
|
2004-07-17 |
2006-02-02 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Methylidene-D-xylopyranosyl and oxo-D-xylopyranosyl-substituted phenyls, medicaments containing these compounds, their use and processes for their preparation
|
TW200606129A
(en)
|
2004-07-26 |
2006-02-16 |
Chugai Pharmaceutical Co Ltd |
Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same
|
JP2008508213A
(en)
|
2004-07-27 |
2008-03-21 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
D-glucopyranosyl-phenyl-substituted cyclics, pharmaceuticals containing such compounds, their use and methods for their production
|
JP2006045156A
(en)
|
2004-08-06 |
2006-02-16 |
Sumitomo Pharmaceut Co Ltd |
Condensed pyrazole derivative
|
WO2006018150A1
(en)
|
2004-08-11 |
2006-02-23 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-phenyl-substituited cyclene, medicaments containing said compounds, use thereof and method for the production thereof
|
TW200613275A
(en)
|
2004-08-24 |
2006-05-01 |
Recordati Ireland Ltd |
Lercanidipine salts
|
EP1782832A4
(en)
|
2004-08-26 |
2009-08-26 |
Takeda Pharmaceutical |
Remedy for diabetes
|
DE102004043944A1
(en)
|
2004-09-11 |
2006-03-30 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Novel 8- (3-amino-piperidin-1-yl) -7- (but-2-ynyl) -xanthines, their preparation and their use as pharmaceuticals
|
DE102004044221A1
(en)
|
2004-09-14 |
2006-03-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
New 3-methyl-7-butynyl xanthines, their preparation and their use as pharmaceuticals
|
CN1759834B
(en)
|
2004-09-17 |
2010-06-23 |
中国医学科学院医药生物技术研究所 |
Application of berberine or associated with Simvastatin in preparing product for preventing or curing disease or symptom related to blood fat
|
AR051446A1
(en)
|
2004-09-23 |
2007-01-17 |
Bristol Myers Squibb Co |
C-ARYL GLUCOSIDS AS SELECTIVE INHIBITORS OF GLUCOSE CONVEYORS (SGLT2)
|
CA2580461A1
(en)
|
2004-09-23 |
2006-04-06 |
Amgen Inc. |
Substituted sulfonamidopropionamides and methods of use
|
DE102004048388A1
(en)
|
2004-10-01 |
2006-04-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
D-pyranosyl-substituted phenyls, pharmaceutical compositions containing them, their use and processes for their preparation
|
MX2007004021A
(en)
|
2004-10-08 |
2007-05-24 |
Novartis Ag |
Combination of organic compounds.
|
JP4959569B2
(en)
|
2004-10-12 |
2012-06-27 |
グレンマーク・ファーマシューティカルズ・エスエー |
Novel dipeptidyl peptidase IV inhibitors, pharmaceutical compositions containing them, and processes for preparing them
|
RU2007119320A
(en)
|
2004-10-25 |
2008-11-27 |
Новартис АГ (CH) |
COMBINATION OF DPP-IV INHIBITOR, PPAR ANTI-DIABETIC AGENT, AND METFORMIN
|
DE102004054054A1
(en)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Process for preparing chiral 8- (3-amino-piperidin-1-yl) -xanthines
|
DE102005013967A1
(en)
|
2004-11-05 |
2006-10-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
New imidazole or pyrimidine derivatives are bradykinin B1 antagonists used for treating e.g. pain, stroke, peptic ulcers and other inflammatory disorders
|
US7687469B2
(en)
|
2004-12-16 |
2010-03-30 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
DE102004063099B4
(en)
|
2004-12-22 |
2009-02-12 |
Sanofi-Aventis Deutschland Gmbh |
Process for the preparation of thiophene glycoside derivatives
|
AU2005320134B2
(en)
|
2004-12-24 |
2011-04-28 |
Dainippon Sumitomo Pharma Co., Ltd. |
Bicyclic pyrrole derivatives
|
KR100760430B1
(en)
|
2004-12-31 |
2007-10-04 |
한미약품 주식회사 |
Controlled release complex formulation for oral administration of medicine for diabetes and method for the preparation thereof
|
DOP2006000008A
(en)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
COMBINED THERAPY FOR THE TREATMENT OF DIABETES AND RELATED AFFECTIONS AND FOR THE TREATMENT OF AFFECTIONS THAT IMPROVE THROUGH AN INCREASE IN THE BLOOD CONCENTRATION OF GLP-1
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
GT200600008A
(en)
|
2005-01-18 |
2006-08-09 |
|
FORMULATION OF DIRECT COMPRESSION AND PROCESS
|
TW200637869A
(en)
|
2005-01-28 |
2006-11-01 |
Chugai Pharmaceutical Co Ltd |
The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
|
WO2006089872A1
(en)
|
2005-02-23 |
2006-08-31 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted ( (hetero)arylethynyl-benzyd-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors
|
ES2338041T3
(en)
|
2005-04-15 |
2010-05-03 |
Boehringer Ingelheim International Gmbh |
DERIVATIVES OF (HETEROARILOXI-BENCIL) -BENZENE SUBSTITUTED WITH GLUCOPIRANOSIL IN QUALITY OF SGLT INHIBITORS.
|
AP2007004234A0
(en)
|
2005-04-22 |
2007-12-31 |
Alantos Pharm Holding |
Dipeptidyl peptidase-IV inhibitors
|
JP4749417B2
(en)
|
2005-04-25 |
2011-08-17 |
株式会社日立製作所 |
Inspection apparatus using magnetic resonance and coil for receiving nuclear magnetic resonance signal
|
US7723309B2
(en)
|
2005-05-03 |
2010-05-25 |
Boehringer Ingelheim International Gmbh |
Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
|
UA91546C2
(en)
|
2005-05-03 |
2010-08-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
Crystalline form of 1-chloro-4-(я-d-glucopyranos-1-yl)-2-[4-((s)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
|
US7772191B2
(en)
|
2005-05-10 |
2010-08-10 |
Boehringer Ingelheim International Gmbh |
Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
|
RU2007143161A
(en)
|
2005-05-25 |
2009-07-10 |
Вайет (Us) |
METHODS FOR SYNTHESIS OF SUBSTITUTED 3-CYANOCHINES AND THEIR PRODUCTS
|
GT200600218A
(en)
|
2005-06-10 |
2007-03-28 |
|
FORMULATION AND PROCESS OF DIRECT COMPRESSION
|
US7585630B2
(en)
|
2005-06-20 |
2009-09-08 |
Decode Genetics Ehf. |
Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus
|
WO2007000445A1
(en)
|
2005-06-29 |
2007-01-04 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
PE20070374A1
(en)
|
2005-07-08 |
2007-05-12 |
Pfizer Ltd |
ANTI-MADCAM ANTIBODIES
|
WO2007014894A2
(en)
|
2005-07-27 |
2007-02-08 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted ( (hetero) cycloalyklethynyl-benzyl) -benzene derivatives and use thereof as sodium-dependent glucose cotransporter (sglt) inhibitors
|
UY29694A1
(en)
|
2005-07-28 |
2007-02-28 |
Boehringer Ingelheim Int |
METHODS TO PREVENT AND TREAT METABOLIC AND NEW DISORDERS DERIVED FROM PIRAZOL-O-GLUCOSIDO
|
DE102005035891A1
(en)
|
2005-07-30 |
2007-02-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8- (3-amino-piperidin-1-yl) -xanthines, their preparation and their use as pharmaceuticals
|
AU2006278039B2
(en)
|
2005-08-11 |
2010-10-21 |
F. Hoffmann-La Roche Ag |
Pharmaceutical composition comprising a DPP-lV inhibitor
|
ATE484499T1
(en)
|
2005-08-30 |
2010-10-15 |
Boehringer Ingelheim Int |
GLUCOPYRANOSYL-SUBSTITUTED BENZYL DERIVATIVES, MEDICATIONS CONTAINING SUCH COMPOUNDS, THEIR USE AND PRODUCTION METHOD THEREOF
|
EP1760076A1
(en)
|
2005-09-02 |
2007-03-07 |
Ferring B.V. |
FAP Inhibitors
|
AU2006289093A1
(en)
|
2005-09-08 |
2007-03-15 |
Boehringer Ingelheim International Gmbh |
Crystalline forms of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-(4-ethynyl-benzyl)-benzene, methods for its preparation and the use thereof for preparing medicaments
|
CA2622472C
(en)
|
2005-09-14 |
2013-11-19 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors for treating diabetes
|
AR056195A1
(en)
|
2005-09-15 |
2007-09-26 |
Boehringer Ingelheim Int |
PROCEDURES TO PREPARE DERIVATIVES OF (ETINIL-BENCIL) -BENZENE REPLACED GLUCOPYRANOSIL AND INTERMEDIATE COMPOUNDS OF THE SAME
|
BRPI0616245A2
(en)
|
2005-09-16 |
2011-06-14 |
Arena Pharm Inc |
metabolism modulator, its uses, a pharmaceutical composition comprising the same as well as a method for producing said composition
|
ATE514435T1
(en)
|
2005-09-20 |
2011-07-15 |
Novartis Pharma Gmbh |
USE OF A DPP-IV INHIBITOR TO REDUCE HYPOGLYCEMIC EVENTS
|
JOP20180109A1
(en)
|
2005-09-29 |
2019-01-30 |
Novartis Ag |
New Formulation
|
AU2006298895B9
(en)
|
2005-09-30 |
2013-01-24 |
Boehringer Ingelheim Vetmedica Gmbh |
Pharmaceutical preparation containing meloxicam
|
WO2007050485A2
(en)
|
2005-10-25 |
2007-05-03 |
Merck & Co., Inc. |
Combination of a dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension
|
JP2009515005A
(en)
|
2005-11-04 |
2009-04-09 |
エルエス ケーブル リミテッド |
Method for producing magnesium hydroxide polymer hybrid particles
|
CA2633167A1
(en)
|
2005-12-16 |
2007-07-12 |
Merck & Co., Inc. |
Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin
|
RU2008129873A
(en)
|
2005-12-23 |
2010-01-27 |
Новартис АГ (CH) |
CONDENSED HETEROCYCLIC COMPOUNDS USEFUL AS DPP-IV INHIBITORS
|
GB0526291D0
(en)
|
2005-12-23 |
2006-02-01 |
Prosidion Ltd |
Therapeutic method
|
WO2007120936A2
(en)
|
2006-01-06 |
2007-10-25 |
Novartis Ag |
Use.of vildagliptin for the treatment of diabetes
|
TW200801029A
(en)
|
2006-02-15 |
2008-01-01 |
Boehringer Ingelheim Int |
Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
|
WO2007099345A1
(en)
|
2006-03-02 |
2007-09-07 |
Betagenon Ab |
Medical use of bmp-2 and/ or bmp-4
|
US8784886B2
(en)
*
|
2006-03-09 |
2014-07-22 |
GlaxoSmithKline, LLC |
Coating capsules with active pharmaceutical ingredients
|
US20070264370A1
(en)
*
|
2006-03-31 |
2007-11-15 |
Jeffers Michael G |
Composition and methods for the treatment of joint pain using Angelica gigas Nakai extract and powder as combined with Glucosamine Sulfate, or Chondroitin Sulfate and HCL, or MSM, or aspirin, or Celedrin, and as combinations thereof in powder, pill, capsule, spray, liquid, and gelcap form
|
PE20071221A1
(en)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
GPR119 RECEPTOR AGONISTS IN METHODS TO INCREASE BONE MASS AND TO TREAT OSTEOPOROSIS AND OTHER CONDITIONS CHARACTERIZED BY LOW BONE MASS, AND COMBINED THERAPY RELATED TO THESE AGONISTS
|
US8455435B2
(en)
|
2006-04-19 |
2013-06-04 |
Ludwig-Maximilians-Universitat Munchen |
Remedies for ischemia
|
PE20080697A1
(en)
|
2006-05-03 |
2008-08-05 |
Boehringer Ingelheim Int |
BENZONITRILE DERIVATIVES SUBSTITUTED WITH GLUCOPYRANOSIL, PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS OF THIS TYPE, THEIR USE AND PROCEDURE FOR THEIR MANUFACTURE
|
PE20080251A1
(en)
|
2006-05-04 |
2008-04-25 |
Boehringer Ingelheim Int |
USES OF DPP IV INHIBITORS
|
EP1852108A1
(en)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
CA2810522A1
(en)
|
2006-05-04 |
2007-11-15 |
Boehringer Ingelheim International Gmbh |
Polymorphs
|
EP2020996B1
(en)
|
2006-05-16 |
2011-11-23 |
Gilead Sciences, Inc. |
Method and compositions for treating hematological malignancies
|
KR20070111099A
(en)
|
2006-05-16 |
2007-11-21 |
영진약품공업주식회사 |
Novel crystalline form of sitagliptin hydrochloride
|
WO2007137107A2
(en)
|
2006-05-19 |
2007-11-29 |
Abbott Laboratories |
Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
|
KR100858848B1
(en)
*
|
2006-05-23 |
2008-09-17 |
한올제약주식회사 |
Pharmaceutical compositions and formulations of Metformin extended release tablets
|
WO2007144175A2
(en)
|
2006-06-16 |
2007-12-21 |
Lek Pharmaceuticals D.D. |
Pharmaceutical composition comprising hydrochlorothiazide and telmisartan
|
WO2007149797A2
(en)
|
2006-06-19 |
2007-12-27 |
Novartis Ag |
Use of organic compounds
|
WO2007148185A2
(en)
|
2006-06-21 |
2007-12-27 |
Pfizer Products Inc. |
Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
|
AT503443B1
(en)
|
2006-06-23 |
2007-10-15 |
Leopold Franzens Uni Innsbruck |
Preparation of an ice surface, useful for ice rink, and ice sports cars and trains, comprises freezing water in which an inorganic substance e.g. ammonia, alkali hydroxide, hydrogen halide, nitric acid and sulfuric acid, is added
|
TW200811147A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
TW200811140A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
JP2010500326A
(en)
|
2006-08-08 |
2010-01-07 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Pyrrolo [3,2-D] pyrimidine as a DPP-IV inhibitor for the treatment of diabetes
|
WO2008020011A1
(en)
|
2006-08-15 |
2008-02-21 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture
|
AU2007285827A1
(en)
|
2006-08-17 |
2008-02-21 |
Wellstat Therapeutics Corporation |
Combination treatment for metabolic disorders
|
US20080221174A1
(en)
*
|
2006-08-30 |
2008-09-11 |
Jagotec Ag |
Controlled release nisoldipine compositions
|
DE102006042586B4
(en)
|
2006-09-11 |
2014-01-16 |
Betanie B.V. International Trading |
Process for the microparticulate loading of high polymer carbohydrates with hydrophobic active fluids
|
US7858587B2
(en)
|
2006-09-21 |
2010-12-28 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted difluorobenzyl-benzene derivates, medicaments containing such compounds, their use and process for their manufacture
|
EP2086991A1
(en)
|
2006-10-27 |
2009-08-12 |
Boehringer Ingelheim International GmbH |
CRYSTALLINE FORM OF 4-(ß-D-GLUCOPYRANOS-1-YL)-1-METHYL-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
|
JP2010508371A
(en)
|
2006-11-06 |
2010-03-18 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Glucopyranosyl-substituted phenyl derivatives, pharmaceuticals containing the compounds, and uses and production methods thereof
|
US7956201B2
(en)
|
2006-11-06 |
2011-06-07 |
Hoffman-La Roche Inc. |
Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one
|
MY157828A
(en)
|
2006-11-09 |
2016-07-29 |
Boehringer Ingelheim Int |
Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions
|
WO2008062273A2
(en)
|
2006-11-20 |
2008-05-29 |
Cadila Pharmaceuticals Limited |
Solid oral dosage form having antidiabetic drug combination
|
US8101634B2
(en)
|
2006-12-06 |
2012-01-24 |
Glaxosmithkline Llc |
Bicyclic compounds and use as antidiabetics
|
US7638541B2
(en)
|
2006-12-28 |
2009-12-29 |
Metabolex Inc. |
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
AR064736A1
(en)
|
2007-01-04 |
2009-04-22 |
Prosidion Ltd |
GPCR AGONISTS
|
CL2008000133A1
(en)
|
2007-01-19 |
2008-05-23 |
Boehringer Ingelheim Int |
PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMPOUND DERIVED FROM PIRAZOL-O-GLUCOSIDE COMBINED WITH AT LEAST A SECOND THERAPEUTIC AGENT; AND USE OF THE COMPOSITION FOR THE TREATMENT OF MELLITUS DIABETES, CATARATS, NEUROPATHY, MYOCARDIAL INFARTS, AND
|
JP2010516721A
(en)
|
2007-01-26 |
2010-05-20 |
サノフィ−アベンティス |
Phenothiazine derivative, its production method and its use as a medicine
|
US20100081625A1
(en)
|
2007-01-26 |
2010-04-01 |
Boehringer Ingelheim International Gmbh |
Methods for preventing and treating neurodegenerative disorders
|
CA2677201C
(en)
|
2007-02-01 |
2015-11-17 |
Takeda Pharmaceutical Company Limited |
Solid preparation comprising alogliptin and pioglitazone
|
TW200836774A
(en)
|
2007-02-01 |
2008-09-16 |
Takeda Pharmaceutical |
Solid preparation
|
ITFI20070042A1
(en)
|
2007-02-21 |
2008-08-22 |
Laboratori Guidotti Spa |
PHARMACEUTICAL FORMULATION AND COMPRESSED INCLUDING THIS FORMULATION.
|
US7879807B2
(en)
|
2007-02-21 |
2011-02-01 |
Boehringer Ingelheim International Gmbh |
Tetrasubstituted glucopyranosylated benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
WO2008101938A1
(en)
|
2007-02-21 |
2008-08-28 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
|
JP2010521492A
(en)
|
2007-03-15 |
2010-06-24 |
ネクティド,インク. |
Anti-diabetic combination comprising sustained release biguanide composition and immediate dipeptidyl peptidase IV inhibitor composition
|
TW200904405A
(en)
|
2007-03-22 |
2009-02-01 |
Bristol Myers Squibb Co |
Pharmaceutical formulations containing an SGLT2 inhibitor
|
TW200904454A
(en)
|
2007-03-22 |
2009-02-01 |
Bristol Myers Squibb Co |
Methods for treating obesity employing an SGLT2 inhibitor and compositions thereof
|
CN103330939A
(en)
|
2007-04-03 |
2013-10-02 |
田边三菱制药株式会社 |
Combined use of dipeptidyl peptidase iv inhibitor compound and sweetener
|
EP2142113B1
(en)
|
2007-04-16 |
2023-01-11 |
Smith & Nephew, Inc. |
Powered surgical system
|
PE20090696A1
(en)
|
2007-04-20 |
2009-06-20 |
Bristol Myers Squibb Co |
CRYSTALLINE FORMS OF SAXAGLIPTIN AND PROCESSES FOR PREPARING THEM
|
JP2010526145A
(en)
|
2007-05-04 |
2010-07-29 |
ブリストル−マイヤーズ スクイブ カンパニー |
[6,6] and [6,7] -bicyclic GPR119G protein-coupled receptor agonists
|
CN101754972A
(en)
|
2007-05-18 |
2010-06-23 |
百时美施贵宝公司 |
Crystalline structure of SGLT2 inhibitor and preparation method thereof
|
BRPI0721862B1
(en)
|
2007-07-09 |
2016-03-15 |
Symrise Ag |
preparation comprising stable soluble salts of phenylbenzimidazole sulfonic acid, and use of basic amino acids
|
KR101536786B1
(en)
|
2007-07-19 |
2015-07-14 |
다케다 야쿠힌 고교 가부시키가이샤 |
Solid preparation comprising alogliptin and metformin hydrochloride
|
PE20090597A1
(en)
|
2007-08-16 |
2009-06-06 |
Boehringer Ingelheim Int |
PHARMACEUTICAL COMPOSITION INCLUDING A DERIVATIVE OF PIRAZOL-O-GLUCOSIDE
|
CL2008002427A1
(en)
|
2007-08-16 |
2009-09-11 |
Boehringer Ingelheim Int |
Pharmaceutical composition comprising 1-chloro-4- (bd-glucopyranos-1-yl) -2- [4 - ((s) -tetrahydrofuran-3-yloxy) benzyl] -benzene combined with 1 - [(4-methylquinazolin- 2-yl) methyl] -3-methyl-7- (2-butyn-1-yl) -8- (3- (r) -aminopiperidin-1-yl) xanthine; and its use to treat type 2 diabetes mellitus.
|
FR2920023B1
(en)
|
2007-08-16 |
2013-02-08 |
Sanofi Aventis |
3-DISUBSTITUTED INDOL-2-ONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
|
CL2008002424A1
(en)
|
2007-08-16 |
2009-09-11 |
Boehringer Ingelheim Int |
Pharmaceutical composition comprising a compound derived from pyrazole-o-glucoside; and use of the pharmaceutical composition for the treatment of diabetes mellitus, abnormal glucose tolerance and hyperglycemia, metabolic disorders, among others.
|
PE20090603A1
(en)
|
2007-08-16 |
2009-06-11 |
Boehringer Ingelheim Int |
PHARMACEUTICAL COMPOSITION INCLUDING A SGLT2 INHIBITOR AND A DPP IV INHIBITOR
|
NZ600126A
(en)
|
2007-08-17 |
2013-12-20 |
Boehringer Ingelheim Int |
Purine derivatives for use in the treatment of fap-related diseases
|
PL2200606T3
(en)
|
2007-09-10 |
2018-08-31 |
Janssen Pharmaceutica, N.V. |
Process for the preparation of compounds useful as inhibitors of sglt
|
CN101861333A
(en)
|
2007-11-16 |
2010-10-13 |
诺沃-诺迪斯克有限公司 |
Pharmaceutical compositions comprising GLP-1 peptides or exendin-4 and a basal insulin peptide
|
CN101234105A
(en)
|
2008-01-09 |
2008-08-06 |
北京润德康医药技术有限公司 |
Pharmaceutical composition containing diabetosan and vildagliptin and preparation thereof
|
US20090186086A1
(en)
|
2008-01-17 |
2009-07-23 |
Par Pharmaceutical, Inc. |
Solid multilayer oral dosage forms
|
CL2008003653A1
(en)
|
2008-01-17 |
2010-03-05 |
Mitsubishi Tanabe Pharma Corp |
Use of a glucopyranosyl-derived sglt inhibitor and a selected dppiv inhibitor to treat diabetes; and pharmaceutical composition.
|
TW200936136A
(en)
|
2008-01-28 |
2009-09-01 |
Sanofi Aventis |
Tetrahydroquinoxaline urea derivatives, their preparation and their therapeutic application
|
CN101932241A
(en)
*
|
2008-02-05 |
2010-12-29 |
默沙东公司 |
Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor
|
US20090226517A1
(en)
*
|
2008-02-06 |
2009-09-10 |
Vinita Umashankar Vyas |
Pharmaceutical formulations comprising duloxetine
|
EP2259676A4
(en)
*
|
2008-03-04 |
2011-03-16 |
Merck Sharp & Dohme |
Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor
|
AU2009220615B2
(en)
|
2008-03-05 |
2013-12-19 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
US8551524B2
(en)
|
2008-03-14 |
2013-10-08 |
Iycus, Llc |
Anti-diabetic combinations
|
US20090270404A1
(en)
|
2008-03-31 |
2009-10-29 |
Metabolex, Inc. |
Oxymethylene aryl compounds and uses thereof
|
PE20140960A1
(en)
|
2008-04-03 |
2014-08-15 |
Boehringer Ingelheim Int |
FORMULATIONS INVOLVING A DPP4 INHIBITOR
|
PE20100156A1
(en)
|
2008-06-03 |
2010-02-23 |
Boehringer Ingelheim Int |
NAFLD TREATMENT
|
UY32030A
(en)
|
2008-08-06 |
2010-03-26 |
Boehringer Ingelheim Int |
"TREATMENT FOR DIABETES IN INAPPROPRIATE PATIENTS FOR THERAPY WITH METFORMIN"
|
MX2011001525A
(en)
|
2008-08-15 |
2011-03-29 |
Boehringer Ingelheim Int |
Purin derivatives for use in the treatment of fab-related diseases.
|
JP2010053576A
(en)
|
2008-08-27 |
2010-03-11 |
Sumitomo Forestry Co Ltd |
Mat for paving
|
CN102149407A
(en)
|
2008-09-10 |
2011-08-10 |
贝林格尔.英格海姆国际有限公司 |
Combination therapy for the treatment of diabetes and related conditions
|
UY32177A
(en)
|
2008-10-16 |
2010-05-31 |
Boehringer Ingelheim Int |
TREATMENT OF DIABETES IN PATIENTS WITH INSUFFICIENT GLUCEMIC CONTROL TO WEIGHT THERAPY WITH DRUG, ORAL OR NOT, ANTIDIABÉTICO
|
WO2010045656A2
(en)
|
2008-10-17 |
2010-04-22 |
Nectid, Inc. |
Novel sglt2 inhibitor dosage forms
|
BRPI0923121A2
(en)
|
2008-12-23 |
2015-08-11 |
Boehringer Ingelheim Int |
Saline forms of organic compounds
|
TW201036975A
(en)
|
2009-01-07 |
2010-10-16 |
Boehringer Ingelheim Int |
Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
|
TWI466672B
(en)
|
2009-01-29 |
2015-01-01 |
Boehringer Ingelheim Int |
Treatment for diabetes in paediatric patients
|
EA029759B1
(en)
|
2009-02-13 |
2018-05-31 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Antidiabetic medications comprising dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetic agents
|
DK2395983T3
(en)
|
2009-02-13 |
2020-07-13 |
Boehringer Ingelheim Int |
PHARMACEUTICAL COMPOSITION INCLUDING AN SGLT2 INHIBITOR, A DPP-IV INHIBITOR AND ANY ADDITIONAL ANTIDIABETIC AGENT AND ITS APPLICATIONS
|
MY161472A
(en)
|
2009-02-13 |
2017-04-14 |
Boehringer Ingelheim Int |
Sglt-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia
|
UY32427A
(en)
|
2009-02-13 |
2010-09-30 |
Boheringer Ingelheim Internat Gmbh |
PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL FORM, PROCEDURE FOR PREPARATION, METHODS OF TREATMENT AND USES OF THE SAME
|
EA024072B1
(en)
|
2009-02-13 |
2016-08-31 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Pharmaceutical dosage form comprising glucopyranosyl diphenylmethane derivative and uses for improving glycemic control in a patient
|
TW201031661A
(en)
|
2009-02-17 |
2010-09-01 |
Targacept Inc |
Fused benzazepines as neuronal nicotinic acetylcholine receptor ligands
|
US20120095028A1
(en)
|
2009-03-20 |
2012-04-19 |
Pfizer Inc. |
3-oxa-7-azabicyclo[3.3.1]nonanes
|
US8815292B2
(en)
|
2009-04-27 |
2014-08-26 |
Revalesio Corporation |
Compositions and methods for treating insulin resistance and diabetes mellitus
|
JP2012528170A
(en)
|
2009-05-27 |
2012-11-12 |
ブリストル−マイヤーズ スクイブ カンパニー |
Method for treating type 2 diabetic patients resistant to prior treatment with another anti-diabetic drug using SGLT2 inhibitors and compositions thereof
|
WO2010140111A1
(en)
*
|
2009-06-02 |
2010-12-09 |
Ranbaxy Laboratories Limited |
Pharmaceutical compositions containing a combination of an antihistamine and a decongestant
|
AU2010260373A1
(en)
|
2009-06-15 |
2012-01-12 |
Merck Sharp & Dohme Corp. |
Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with pioglitazone
|
CN108938585A
(en)
|
2009-07-21 |
2018-12-07 |
凯克斯生物制药公司 |
Ferric citrate dosage forms
|
EP2483286B1
(en)
|
2009-09-30 |
2016-07-13 |
Boehringer Ingelheim International GmbH |
Method for the preparation of a crystalline form of 1-chloro-4-(beta-d-glucopyranos-1-yl)-2-(4-((s)-tetrahydrofuran-3-yloxy)benzyl)benzene
|
WO2011039108A2
(en)
|
2009-09-30 |
2011-04-07 |
Boehringer Ingelheim International Gmbh |
Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives
|
UY32919A
(en)
|
2009-10-02 |
2011-04-29 |
Boehringer Ingelheim Int |
Pharmaceutical composition, pharmaceutical dosage form, procedure for its preparation, methods for its treatment and its uses
|
NZ598170A
(en)
|
2009-10-02 |
2014-06-27 |
Boehringer Ingelheim Int |
Pharmaceutical compositions comprising bi-1356 and metformin
|
BR112012011726A2
(en)
*
|
2009-11-13 |
2020-05-19 |
Bristol-Myers Squibb Company |
two-layer tablets, their use, and their pharmaceutical combinations
|
DK2498759T3
(en)
|
2009-11-13 |
2018-11-26 |
Astrazeneca Ab |
TABLE FORMULATIONS WITH IMMEDIATE RELEASE
|
ES2760917T3
(en)
|
2009-11-27 |
2020-05-18 |
Boehringer Ingelheim Int |
Treatment of diabetic patients genotyped with DPP-IV inhibitors such as linagliptin
|
JP2010070576A
(en)
|
2009-12-28 |
2010-04-02 |
Sato Pharmaceutical Co Ltd |
Rapidly soluble tablet
|
WO2011113947A1
(en)
|
2010-03-18 |
2011-09-22 |
Boehringer Ingelheim International Gmbh |
Combination of a gpr119 agonist and the dpp-iv inhibitor linagliptin for use in the treatment of diabetes and related conditions
|
EP2368552A1
(en)
|
2010-03-25 |
2011-09-28 |
Boehringer Ingelheim Vetmedica GmbH |
1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-xanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animal
|
JP2013523681A
(en)
|
2010-03-30 |
2013-06-17 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Pharmaceutical composition comprising SGLT2 inhibitor and PPAR-gamma agonist and use thereof
|
KR20130069615A
(en)
|
2010-05-05 |
2013-06-26 |
베링거 인겔하임 인터내셔날 게엠베하 |
Pharmaceutical formulations comprising pioglitazone and linagliptin
|
JP6034781B2
(en)
|
2010-05-05 |
2016-11-30 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Combination therapy
|
AU2011271124A1
(en)
|
2010-06-22 |
2013-01-10 |
Twi Pharmaceuticals, Inc. |
Controlled release compositions with reduced food effect
|
CA3164653A1
(en)
|
2010-06-24 |
2011-12-29 |
Boehringer Ingelheim International Gmbh |
A combination comprising linagliptin and a long-acting insulin
|
US20130224296A1
(en)
|
2010-09-03 |
2013-08-29 |
Bristol-Myers Squibb Company |
Drug Formulations Using Water Soluble Antioxidants
|
US20120283169A1
(en)
|
2010-11-08 |
2012-11-08 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
US9034883B2
(en)
|
2010-11-15 |
2015-05-19 |
Boehringer Ingelheim International Gmbh |
Vasoprotective and cardioprotective antidiabetic therapy
|
WO2012088682A1
(en)
|
2010-12-29 |
2012-07-05 |
Shanghai Fochon Pharmaceutical Co Ltd. |
2-(3-aminopiperidin-1-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7(3h,6h)-dione derivates as dipeptidyl peptidase iv(dpp-iv) inhibitors
|
AU2012212448B9
(en)
|
2011-02-01 |
2015-06-25 |
Astrazeneca Uk Limited |
Pharmaceutical formulations including an amine compound
|
US20130035281A1
(en)
|
2011-02-09 |
2013-02-07 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
AR085689A1
(en)
|
2011-03-07 |
2013-10-23 |
Boehringer Ingelheim Int |
PHARMACEUTICAL COMPOSITIONS OF METFORMIN, LINAGLIPTINE AND AN SGLT-2 INHIBITOR
|
WO2012152837A1
(en)
|
2011-05-10 |
2012-11-15 |
Sandoz Ag |
Polymorph of linagliptin benzoate
|
AU2012264736A1
(en)
|
2011-06-03 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
SGLT-2 inhibitors for treating metabolic disorders in patients treated with neuroleptic agents
|
US20130035298A1
(en)
|
2011-07-08 |
2013-02-07 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
US8883800B2
(en)
|
2011-07-15 |
2014-11-11 |
Boehringer Ingelheim International Gmbh |
Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
|
DE102011109492A1
(en)
|
2011-08-04 |
2013-02-07 |
GM Global Technology Operations LLC (n. d. Gesetzen des Staates Delaware) |
Driving assistance device to support the driving of narrow roads
|
US20130172244A1
(en)
|
2011-12-29 |
2013-07-04 |
Thomas Klein |
Subcutaneous therapeutic use of dpp-4 inhibitor
|
CN106968050B
(en)
|
2012-01-04 |
2019-08-27 |
宝洁公司 |
Fibre structure containing active material with multiple regions
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
US9192617B2
(en)
|
2012-03-20 |
2015-11-24 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
EP2849755A1
(en)
|
2012-05-14 |
2015-03-25 |
Boehringer Ingelheim International GmbH |
A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
|
WO2013174767A1
(en)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
|
EP2854812A1
(en)
|
2012-05-24 |
2015-04-08 |
Boehringer Ingelheim International GmbH |
A xanthine derivative as dpp -4 inhibitor for use in the treatment of autoimmune diabetes, particularly lada
|
WO2013179307A2
(en)
|
2012-05-29 |
2013-12-05 |
Mylan Laboratories Limited |
Stabilized pharmaceutical compositions of saxagliptin
|
CA2903577C
(en)
|
2013-03-15 |
2023-10-17 |
Boehringer Ingelheim International Gmbh |
Use of linagliptin in cardio- and renoprotective antidiabetic therapy
|
HUE041709T2
(en)
|
2013-04-05 |
2019-05-28 |
Boehringer Ingelheim Int |
Therapeutic uses of empagliflozin
|
US20140303097A1
(en)
|
2013-04-05 |
2014-10-09 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
AU2014255727B2
(en)
|
2013-04-18 |
2019-07-25 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
CN105283187A
(en)
|
2013-06-14 |
2016-01-27 |
勃林格殷格翰国际有限公司 |
Dpp-4 inhibitors for treating diabetes and its complications
|
EP3110449B1
(en)
|
2014-02-28 |
2023-06-28 |
Boehringer Ingelheim International GmbH |
Medical use of a dpp-4 inhibitor
|